Literature DB >> 27965153

Covalent inhibition of carboxylesterase-2 by sofosbuvir and its effect on the hydrolytic activation of tenofovir disoproxil.

Yuanjun Shen1, Bingfang Yan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27965153     DOI： 10.1016/j.jhep.2016.11.025

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  7 in total

1.  Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism.

Authors:  Rebekah R Shippy; Xiaochen Lin; Sherry S Agabiti; Jin Li; Brendan M Zangari; Benjamin J Foust; Michael M Poe; Chia-Hung Christine Hsiao; Olga Vinogradova; David F Wiemer; Andrew J Wiemer
Journal:  J Med Chem       Date:  2017-03-01       Impact factor: 7.446

2.  Increased tenofovir monoester concentrations in patients receiving tenofovir disoproxil fumarate with ledipasvir/sofosbuvir.

Authors:  Kristina M Brooks; Jose R Castillo-Mancilla; Joshua Blum; Ryan Huntley; Samantha MaWhinney; Keisha Alexander; Becky Jo Kerr; Lucas Ellison; Lane R Bushman; Christine E MacBrayne; Peter L Anderson; Jennifer J Kiser
Journal:  J Antimicrob Chemother       Date:  2019-08-01       Impact factor: 5.790

3.  The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro.

Authors:  Yue Shen; William Eades; William Liu; Bingfang Yan
Journal:  Drug Metab Dispos       Date:  2022-07-05       Impact factor: 3.579

4.  Effect of Sofosbuvir/Ledipasvir and Glecaprevir/Pibrentasvir on Serum Creatinine.

Authors:  Waseem Amjad; Talan Zhang; Anurag Maheshwari; Paul J Thuluvath
Journal:  J Clin Exp Hepatol       Date:  2021-08-20

5.  Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate.

Authors:  Christine E MacBrayne; Kristen M Marks; Daniel S Fierer; Susanna Naggie; Raymond T Chung; Michael D Hughes; Arthur Y Kim; Marion G Peters; Diana M Brainard; Sharon M Seifert; Jose R Castillo-Mancilla; Lane R Bushman; Peter L Anderson; Jennifer J Kiser
Journal:  J Antimicrob Chemother       Date:  2018-08-01       Impact factor: 5.790

Review 6.  The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance.

Authors:  Daisy Yan; One Hyuk Ra; Bingfang Yan
Journal:  Anim Dis       Date:  2021-09-07

Review 7.  Human carboxylesterases and fluorescent probes to image their activity in live cells.

Authors:  Anchal Singh; Mingze Gao; Michael W Beck
Journal:  RSC Med Chem       Date:  2021-05-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.